Administration of dexamethasone in the postoperative period after 1- or 2-level PLSF may be associated with a higher risk of SSI and instrumentation complications at 30 days, 90 days, and 1 year in diabetic patients undergoing elective 1- or 2-level lumbar fusion.
Johnson et al. (Fri,) studied this question.